Interviews

During this year’s European Society of Respiratory (ERS) International Congress, we spoke to Prof Geoffrey Maksym, Director, Professor, School…

Catalina Cernica is Head of Innovation Lab UK and Global Project Director at LEO Innovation Lab, alongside her role as CEO of the Health and Happiness…

Ingeborg R. Borgheim holds a senior leadership position at Takeda and leads the Nordic Region. We spoke to Ingeborg at eyeforpharma, Barcelona…

At the Curious2018 – Future Insight Conference, as part of Merck’s 350th anniversary, Stefan Oschmann, CEO, Merck, announced the Future Insight Prize.

For International Non-Alcoholic Steatohepatitis (NASH) Day, we spoke to Mike about Gilead’s approach to tackling NASH and future diagnosis options…

Prof Ahmad Awada is Head of Oncology Medicine Department at the Jules Bordet Institute, Brussels, Belgium, and specialises in the…

Atrial Fibrillation (AF) is the most common arrhythmia (irregular heart rhythm disorder), which is having a huge and increasing burden on patients…

Jennifer Turgiss leads the behaviour science and analytics teams at Johnson & Johnson (J&J), applying her expertise in behavioural and social science to develop digital health behaviour change interventions. We spoke to Jennifer at this year’s eyeforpharma, Barcelona on her long-standing career in the Health and Wellness industry and scaling bespoke patient behaviour change programmes.